The relationship between dietary fatty acids and inflammatory genes on the obese phenotype and serum lipids

Nutrients

Volumn 5, Issue 5, 2013, Pages 1672-1705

  Joffe, Yael T ^a   Collins, Malcolm ^a,b   Goedecke, Julia H ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

Adipose tissue; Dietary fat; Dyslipidemia; Ethnicity; Inflammation; SNP

Indexed keywords

INTERLEUKIN 6; LIPID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; SATURATED FATTY ACID; TUMOR NECROSIS FACTOR ALPHA;

CYTOKINE PRODUCTION; ETHNICITY; FAT INTAKE; GENE FREQUENCY; GENE INTERACTION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INFLAMMATION; INTERLEUKIN 6 GENE; LIPID BLOOD LEVEL; NONHUMAN; OBESITY; PHENOTYPIC VARIATION; REVIEW; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR NECROSIS FACTOR ALPHA GENE;

EID: 84878209206     PISSN: 20726643     EISSN: None     Source Type: Journal    
DOI: 10.3390/nu5051672     Document Type: Review

References (142)

1. Maury, E.; Brichard, S.M. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol. Cell. Endocrinol. 2010, 314, 1-16.
2. Bray, M.S. Implications of gene-behavior interactions: Prevention and intervention for obesity. Obesity 2008, 16 (Suppl. 3), S72-S78.
3. Joffe, Y.T.; van der Merwe, L.; Carstens, M.; Collins, M.; Jennings, C.; Levitt, N.S.; Lambert, E.V.; Goedecke, J.H. Tumor necrosis factor-α gene -308 G/A polymorphism modulates the relationship between dietary fat intake, serum lipids, and obesity risk in black South African women. J. Nutr. 2010, 140, 901-907.
4. Joffe, Y.T.; van der Merwe, L.; Collins, M.; Carstens, M.; Evans, J.; Lambert, E.V.; Goedecke, J.H. The -308 G/A polymorphism of the tumour necrosis factor-α gene modifies the association between saturated fat intake and serum total cholesterol levels in white South African women. Genes Nutr. 2011, 6, 353-359.
5. Joffe, Y.T.; van der Merwe, L.; Evans, J.; Collins, M.; Lambert, E.V.; September, A.; Goedecke, J.H. The tumor necrosis factor-α gene -238 G > A polymorphism, dietary fat intake, obesity risk and serum lipid concentrations in black and white South African women. Eur. J. Clin. Nutr. 2012, 66, 1295-1302.
6. Stryjecki, C.; Mutch, D.M. Fatty acid-gene interactions, adipokines and obesity. Eur. J. Clin. Nutr. 2011, 65, 285-297.
7. Fantuzzi, G. Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol. 2005, 115, 911-919.
8. Nair, S.; Lee, Y.H.; Rousseau, E.; Cam, M.; Tataranni, P.A.; Baier, L.J.; Bogardus, C.; Permana, P.A. Increased expression of inflammation-related genes in cultured preadipocytes/stromal vascular cells from obese compared with non-obese Pima Indians. Diabetologia 2005, 48, 1784-1788.
9. Gutierrez, D.A.; Puglisi, M.J.; Hasty, A.H. Impact of increased adipose tissue mass on inflammation, insulin resistance, and dyslipidemia. Curr. Diabetes Rep. 2009, 9, 26-32.
10. Weisberg, S.P.; McCann, D.; Desai, M.; Rosenbaum, M.; Leibel, R.L.; Ferrante, A.W., Jr. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112, 1796-1808.
11. Galic, S.; Oakhill, J.S.; Steinberg, G.R. Adipose tissue as an endocrine organ. Mol. Cell. Endocrinol. 2010, 316, 129-139.
12. Xu, H.; Barnes, G.T.; Yang, Q.; Tan, G.; Yang, D.; Chou, C.J.; Sole, J.; Nichols, A.; Ross, J.S.; Tartaglia, L.A.; et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 2003, 112, 1821-1830.
13. Libby, P.; Ridker, P.M.; Maseri, A. Inflammation and atherosclerosis. Circulation 2002, 105, 1135-1143.
14. Berliner, J.; Leitinger, N.; Watson, A.; Huber, J.; Fogelman, A.; Navab, M. Oxidized lipids in atherogenesis: Formation, destruction and action. Thromb. Haemost. 1997, 78, 195-199.
15. Sugiyama, S.; Okada, Y.; Sukhova, G.K.; Virmani, R.; Heinecke, J.W.; Libby, P. Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am. J. Pathol. 2001, 158, 879-891.
16. Dichtl, W.; Nilsson, L.; Goncalves, I.; Ares, M.P.; Banfi, C.; Calara, F.; Hamsten, A.; Eriksson, P.; Nilsson, J. Very low-density lipoprotein activates nuclear factor-κB in endothelial cells. Circ. Res. 1999, 84, 1085-1094.
17. Burzotta, F.; Iacoviello, L.; Di Castelnuovo, A.; Glieca, F.; Luciani, N.; Zamparelli, R.; Schiavello, R.; Donati, M.B.; Maseri, A.; Possati, G.; et al. Relation of the -174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization. Am. J. Cardiol. 2001, 88, 1125-1128.
18. Santtila, S.; Savinainen, K.; Hurme, M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1β production in vitro. Scand. J. Immunol. 1998, 47, 195-198.
19. Terry, C.F.; Loukaci, V.; Green, F.R. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J. Biol. Chem. 2000, 275, 18138-18144.
20. Wilson, A.G.; Symons, J.A.; McDowell, T.L.; McDevitt, H.O.; Duff, G.W. Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc. Natl. Acad. Sci. USA 1997, 94, 3195-3199.
21. Yu, Z.; Han, S.; Cao, X.; Zhu, C.; Wang, X.; Guo, X. Genetic polymorphisms in adipokine genes and the risk of obesity: A systematic review and meta-analysis. Obesity 2011, 20, 396-406.
22. Phillips, C.M. Nutrigenetics and metabolic disease: Current status and implications for personalised nutrition. Nutrients 2013, 5, 32-57.
23. Phillips, C.M.; Goumidi, L.; Bertrais, S.; Ferguson, J.F.; Field, M.R.; Kelly, E.D.; Mehegan, J.; Peloso, G.M.; Cupples, L.A.; Shen, J. et al. Additive effect of polymorphisms in the IL-6, LTA, and TNF-α genes and plasma fatty acid level modulate risk for the metabolic syndrome and its components. J. Clin. Endocrinol. Metab. 2010, 95, 1386-1394.
24. Calder, P.C. n-3 polyunsaturated fatty acids and inflammation: From molecular biology to the clinic. Lipids 2003, 38, 343-352.
25. Calder, P.C. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am. J. Clin. Nutr. 2006, 83, 1505S-1519S.
26. Van den Berghe, W.; Vermeulen, L.; Delerive, P.; De Bosscher, K.; Staels, B.; Haegeman, G. A paradigm for gene regulation: Inflammation, NF-κB and PPAR. Adv. Exp. Med. Biol. 2003, 544, 181-196.
27. Calder, P.C.; Ahluwalia, N.; Brouns, F.; Buetler, T.; Clement, K.; Cunningham, K.; Esposito, K.; Jonsson, L.S.; Kolb, H.; Lansink, M.; et al. Dietary factors and low-grade inflammation in relation to overweight and obesity. Br. J. Nutr. 2011, 106 (Suppl. 3), S5-S78.
28. Suganami, T.; Tanimoto-Koyama, K.; Nishida, J.; Itoh, M.; Yuan, X.; Mizuarai, S.; Kotani, H.; Yamaoka, S.; Miyake, K.; Aoe, S.; et al. Role of the Toll-like receptor 4/NF-κB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 84-91.
29. Fessler, M.B.; Rudel, L.L.; Brown, J.M. Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome. Curr. Opin. Lipidol. 2009, 20, 379-385.
30. Weatherill, A.R.; Lee, J.Y.; Zhao, L.; Lemay, D.G.; Youn, H.S.; Hwang, D.H. Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4. J. Immunol. 2005, 174, 5390-5397.
31. Ajuwon, K.M.; Spurlock, M.E. Palmitate activates the NF-κB transcription factor and induces IL-6 and TNFα expression in 3T3-L1 adipocytes. J. Nutr. 2005, 135, 1841-1846.
32. Weigert, C.; Brodbeck, K.; Staiger, H.; Kausch, C.; Machicao, F.; Haring, H.U.; Schleicher, E.D. Palmitate, but not unsaturated fatty acids, induces the expression of interleukin-6 in human myotubes through proteasome-dependent activation of nuclear factor-κB. J. Biol. Chem. 2004, 279, 23942-23952.
33. Lee, J.Y.; Plakidas, A.; Lee, W.H.; Heikkinen, A.; Chanmugam, P.; Bray, G.; Hwang, D.H. Differential modulation of Toll-like receptors by fatty acids: Preferential inhibition by n-3 polyunsaturated fatty acids. J. Lipid Res. 2003, 44, 479-486.
34. Baum, S.J.; Kris-Etherton, P.M.; Willett, W.C.; Lichtenstein, A.H.; Rudel, L.L.; Maki, K.C.; Whelan, J.; Ramsden, C.E.; Block, R.C. Fatty acids in cardiovascular health and disease: A comprehensive update. J. Clin. Lipidol. 2012, 6, 216-234.
35. Pischon, T.; Hankinson, S.E.; Hotamisligil, G.S.; Rifai, N.; Willett, W.C.; Rimm, E.B. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 2003, 108, 155-160.
36. Bjermo, H.; Iggman, D.; Kullberg, J.; Dahlman, I.; Johansson, L.; Persson, L.; Berglund, J.; Pulkki, K.; Basu, S.; Uusitupa, M.; et al. Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: A randomized controlled trial. Am. J. Clin. Nutr. 2012, 95, 1003-1012.
37. Kelley, D.S.; Taylor, P.C.; Nelson, G.J.; Schmidt, P.C.; Mackey, B.E.; Kyle, D. Effects of dietary arachidonic acid on human immune response. Lipids 1997, 32, 449-456.
38. Thies, F.; Miles, E.A.; Nebe-von-Caron, G.; Powell, J.R.; Hurst, T.L.; Newsholme, E.A.; Calder, P.C. Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Lipids 2001, 36, 1183-1193.
39. Thies, F.; Nebe-von-Caron, G.; Powell, J.R.; Yaqoob, P.; Newsholme, E.A.; Calder, P.C. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged > 55 y. Am. J. Clin. Nutr. 2001, 73, 539-548.
40. Erkkila, A.; de Mello, V.D.; Riserus, U.; Laaksonen, D.E. Dietary fatty acids and cardiovascular disease: An epidemiological approach. Prog. Lipid Res. 2008, 47, 172-187.
41. Williams, C.M.; Burdge, G. Long-chain n-3 PUFA: Plant v. marine sources. Proc. Nutr. Soc. 2006, 65, 42-50.
42. Stulnig, T.M. Immunomodulation by polyunsaturated fatty acids: Mechanisms and effects. Int. Arch. Allergy Immunol. 2003, 132, 310-321.
43. Zhao, G.; Etherton, T.D.; Martin, K.R.; Gillies, P.J.; West, S.G.; Kris-Etherton, P.M. Dietary α-linolenic acid inhibits proinflammatory cytokine production by peripheral blood mononuclear cells in hypercholesterolemic subjects. Am. J. Clin. Nutr. 2007, 85, 385-391.
44. Zhao, G.; Etherton, T.D.; Martin, K.R.; West, S.G.; Gillies, P.J.; Kris-Etherton, P.M. Dietary alpha-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. J. Nutr. 2004, 134, 2991-2997.
45. Calder, P.C. Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale. Biochimie 2009, 91, 791-795.
46. Bray, G.A.; Lovejoy, J.C.; Smith, S.R.; DeLany, J.P.; Lefevre, M.; Hwang, D.; Ryan, D.H.; York, D.A. The influence of different fats and fatty acids on obesity, insulin resistance and inflammation. J. Nutr. 2002, 132, 2488-2491.
47. Itariu, B.K.; Zeyda, M.; Hochbrugger, E.E.; Neuhofer, A.; Prager, G.; Schindler, K.; Bohdjalian, A.; Mascher, D.; Vangala, S.; Schranz, M. et al. Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: A randomized controlled trial. Am. J. Clin. Nutr. 2012, 96, 1137-1149.
48. Simopoulos, A.P. Omega-3 fatty acids in inflammation and autoimmune diseases. J. Am. Coll. Nutr. 2002, 21, 495-505.
49. Maury, E.; Noel, L.; Detry, R.; Brichard, S.M. In vitro hyperresponsiveness to tumor necrosis factor-α contributes to adipokine dysregulation in omental adipocytes of obese subjects. J. Clin. Endocrinol. Metab. 2009, 94, 1393-1400.
50. Suganami, T.; Nishida, J.; Ogawa, Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: Role of free fatty acids and tumor necrosis factor α. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 2062-2068.
51. Dandona, P.; Weinstock, R.; Thusu, K.; Abdel-Rahman, E.; Aljada, A.; Wadden, T. Tumor necrosis factor-α in sera of obese patients: Fall with weight loss. J. Clin. Endocrinol. Metab. 1998, 83, 2907-2910.
52. Wang, B.; Trayhurn, P. Acute and prolonged effects of TNF-α on the expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture. Pflug. Archiv. Eur. J. Physiol. 2006, 452, 418-427.
53. Bruun, J.M.; Lihn, A.S.; Verdich, C.; Pedersen, S.B.; Toubro, S.; Astrup, A.; Richelsen, B. Regulation of adiponectin by adipose tissue-derived cytokines: In vivo and in vitro investigations in humans. Am. J. Physiol. Endocrinol. Metab. 2003, 285, E527-E533.
54. Ruan, H.; Hacohen, N.; Golub, T.R.; Van Parijs, L.; Lodish, H.F. Tumor necrosis factor-α suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: Nuclear factor-κB activation by TNF-α is obligatory. Diabetes 2002, 51, 1319-1336.
55. Chen, X.; Xun, K.; Chen, L.; Wang, Y. TNF-α, a potent lipid metabolism regulator. Cell Biochem. Funct. 2009, 27, 407-416.
56. Madej, A.; Okopien, B.; Kowalski, J.; Zielinski, M.; Wysocki, J.; Szygula, B.; Kalina, Z.; Herman, Z. Levels of tumor necrosis factor alpha in serum of patients with hyperlipoproteinemia IIB before and after micronized fenofibrate therapy. Pol. Arch. Med. Wewn. 1998, 99, 308-313.
57. Ascer, E.; Bertolami, M.C.; Venturinelli, M.L.; Buccheri, V.; Souza, J.; Nicolau, J.C.; Ramires, J.A.; Serrano, C.V., Jr. Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients. Atherosclerosis 2004, 177, 161-166.
58. Marketou, M.E.; Zacharis, E.A.; Nikitovic, D.; Ganotakis, E.S.; Parthenakis, F.I.; Maliaraki, N.; Vardas, P.E. Early effects of simvastatin versus atorvastatin on oxidative stress and proinflammatory cytokines in hyperlipidemic subjects. Angiology 2006, 57, 211-218.
59. Popa, C.; Netea, M.G.; Radstake, T.; van der Meer, J.W.; Stalenhoef, A.F.; van Riel, P.L.; Barerra, P. Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis. Ann. Rheum Dis. 2005, 64, 303-305.
60. Feingold, K.R.; Grunfeld, C. Role of cytokines in inducing hyperlipidemia. Diabetes 1992, 41 (Suppl. 2), 97-101.
61. Feingold, K.R.; Soued, M.; Staprans, I.; Gavin, L.A.; Donahue, M.E.; Huang, B.J.; Moser, A.H.; Gulli, R.; Grunfeld, C. Effect of tumor necrosis factor (TNF) on lipid metabolism in the diabetic rat. Evidence that inhibition of adipose tissue lipoprotein lipase activity is not required for TNF-induced hyperlipidemia. J. Clin. Invest. 1989, 83, 1116-1121.
62. Bradley, R.L.; Fisher, F.F.; Maratos-Flier, E. Dietary fatty acids differentially regulate production of TNF-α and IL-10 by murine 3T3-L1 adipocytes. Obesity 2008, 16, 938-944.
63. Chandrasekar, B.; Fernandes, G. Decreased pro-inflammatory cytokines and increased antioxidant enzyme gene expression by omega-3 lipids in murine lupus nephritis. Biochem. Biophys. Res. Commun. 1994, 200, 893-898.
64. Perez-Matute, P.; Perez-Echarri, N.; Martinez, J.A.; Marti, A.; Moreno-Aliaga, M.J. Eicosapentaenoic acid actions on adiposity and insulin resistance in control and high-fat-fed rats: Role of apoptosis, adiponectin and tumour necrosis factor-α. Br. J. Nutr. 2007, 97, 389-398.
65. Caughey, G.E.; Mantzioris, E.; Gibson, R.A.; Cleland, L.G.; James, M.J. The effect on human tumor necrosis factor alpha and interleukin 1 β production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am. J. Clin. Nutr. 1996, 63, 116-122.
66. Endres, S.; Ghorbani, R.; Kelley, V.E.; Georgilis, K.; Lonnemann, G.; van der Meer, J.W.; Cannon, J.G.; Rogers, T.S.; Klempner, M.S.; Weber, P.C. et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N. Engl. J. Med. 1989, 320, 265-271.
67. Grimble, R.F.; Howell, W.M.; O'Reilly, G.; Turner, S.J.; Markovic, O.; Hirrell, S.; East, J.M.; Calder, P.C. The ability of fish oil to suppress tumor necrosis factor α a production by peripheral blood mononuclear cells in healthy men is associated with polymorphisms in genes that influence tumor necrosis factor α production. Am. J. Clin. Nutr. 2002, 76, 454-459.
68. Brand, E.; Schorr, U.; Kunz, I.; Kertmen, E.; Ringel, J.; Distler, A.; Sharma, A.M. Tumor necrosis factor-α: 308 G/A polymorphism in obese Caucasians. Int. J. Obes. Relat. Metab. Disord. 2001, 25, 581-585.
69. Herrmann, S.M.; Ricard, S.; Nicaud, V.; Mallet, C.; Arveiler, D.; Evans, A.; Ruidavets, J.B.; Luc, G.; Bara, L.; Parra, H.J. et al. Polymorphisms of the tumour necrosis factor-α gene, coronary heart disease and obesity. Eur. J. Clin. Invest. 1998, 28, 59-66.
70. Hoffstedt, J.; Eriksson, P.; Hellstrom, L.; Rossner, S.; Ryden, M.; Arner, P. Excessive fat accumulation is associated with the TNF α -308 G/A promoter polymorphism in women but not in men. Diabetologia 2000, 43, 117-120.
71. Nieters, A.; Becker, N.; Linseisen, J. Polymorphisms in candidate obesity genes and their interaction with dietary intake of n-6 polyunsaturated fatty acids affect obesity risk in a sub-sample of the EPIC-Heidelberg cohort. Eur. J. Nutr. 2002, 41, 210-221.
72. Pihlajamaki, J.; Ylinen, M.; Karhapaa, P.; Vauhkonen, I.; Laakso, M. The effect of the -308A allele of the TNF-α gene on insulin action is dependent on obesity. Obes. Res. 2003, 11, 912-917.
73. Rosmond, R.; Chagnon, M.; Bouchard, C.; Bjorntorp, P. G-308A polymorphism of the tumor necrosis factor α gene promoter and salivary cortisol secretion. J. Clin. Endocrinol. Metab. 2001, 86, 2178-2180.
74. Sookoian, S.; Garcia, S.I.; Gianotti, T.F.; Dieuzeide, G.; Gonzalez, C.D.; Pirola, C.J. The G-308A promoter variant of the tumor necrosis factor-α gene is associated with hypertension in adolescents harboring the metabolic syndrome. Am. J. Hypertens. 2005, 18, 1271-1275.
75. Dalziel, B.; Gosby, A.K.; Richman, R.M.; Bryson, J.M.; Caterson, I.D. Association of the TNF-α -308 G/A promoter polymorphism with insulin resistance in obesity. Obes. Res. 2002, 10, 401-407.
76. Wybranska, I.; Malczewska-Malec, M.; Niedbal, S.; Naskalski, J.W.; Dembinska-Kiec, A. The TNF-α gene NcoI polymorphism at position -308 of the promoter influences insulin resistance, and increases serum triglycerides after postprandial lipaemia in familiar obesity. Clin. Chem. Lab. Med. 2003, 41, 501-510.
77. Weldon, S.M.; Mullen, A.C.; Loscher, C.E.; Hurley, L.A.; Roche, H.M. Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid. J. Nutr. Biochem. 2007, 18, 250-258.
78. Davis, J.E.; Gabler, N.K.; Walker-Daniels, J.; Spurlock, M.E. Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat. Obesity 2008, 16, 1248-1255.
79. Garcia-Escobar, E.; Rodriguez-Pacheco, F.; Garcia-Serrano, S.; Gomez-Zumaquero, J.M.; Haro-Mora, J.J.; Soriguer, F.; Rojo-Martinez, G. Nutritional regulation of interleukin-6 release from adipocytes. Int. J. Obes. (Lond.) 2010, 34, 1328-1332.
80. Van Dijk, S.J.; Feskens, E.J.; Bos, M.B.; Hoelen, D.W.; Heijligenberg, R.; Bromhaar, M.G.; de Groot, L.C.; de Vries, J.H.; Muller, M.; Afman, L.A. A saturated fatty acid-rich diet induces an obesity-linked proinflammatory gene expression profile in adipose tissue of subjects at risk of metabolic syndrome. Am. J. Clin. Nutr. 2009, 90, 1656-1664.
81. He, K.; Liu, K.; Daviglus, M.L.; Jenny, N.S.; Mayer-Davis, E.; Jiang, R.; Steffen, L.; Siscovick, D.; Tsai, M.; Herrington, D. Associations of dietary long-chain n-3 polyunsaturated fatty acids and fish with biomarkers of inflammation and endothelial activation (from the Multi-Ethnic Study of Atherosclerosis [MESA]). Am. J. Cardiol. 2009, 103, 1238-1243.
82. Ferrucci, L.; Cherubini, A.; Bandinelli, S.; Bartali, B.; Corsi, A.; Lauretani, F.; Martin, A.; Andres-Lacueva, C.; Senin, U.; Guralnik, J.M. Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J. Clin. Endocrinol. Metab. 2006, 91, 439-446.
83. Romeo, S.; Sentinelli, F.; Capici, F.; Arca, M.; Berni, A.; Vecci, E.; Di Mario, U.; Baroni, M.G. The G-308A variant of the Tumor Necrosis Factor-alpha (TNF-α) gene is not associated with obesity, insulin resistance and body fat distribution. BMC Med. Genet. 2001, 2, 10.
84. Um, J.Y.; Park, J.H.; Kim, H.M. Gene polymorphisms in tumor necrosis factor locus and waist-hip ratio in obese Koreans. Clin. Chim. Acta 2003, 338, 117-122.
85. Hedayati, M.; Sharifi, K.; Rostami, F.; Daneshpour, M.S.; Zarif Yeganeh, M.; Azizi, F. Association between TNF-α promoter G-308A and G-238A polymorphisms and obesity. Mol. Biol. Rep. 2011, 39, 825-829.
86. Walston, J.; Seibert, M.; Yen, C.J.; Cheskin, L.J.; Andersen, R.E. Tumor necrosis factor-α-238 and -308 polymorphisms do not associated with traits related to obesity and insulin resistance. Diabetes 1999, 48, 2096-2098.
87. Riikola, A.; Sipila, K.; Kahonen, M.; Jula, A.; Nieminen, M.S.; Moilanen, L.; Kesaniemi, Y.A.; Lehtimaki, T.; Hulkkonen, J. Interleukin-6 promoter polymorphism and cardiovascular risk factors: The Health 2000 Survey. Atherosclerosis 2009, 207, 466-470.
88. Huth, C.; Illig, T.; Herder, C.; Gieger, C.; Grallert, H.; Vollmert, C.; Rathmann, W.; Hamid, Y.H.; Pedersen, O.H.; Hansen, T.; et al. Joint analysis of individual participants' data from 17 studies on the association of the IL6 variant -174G > C with circulating glucose levels, interleukin-6 levels, and body mass index. Ann. Med. 2009, 41, 128-138.
89. Qi, L.; Zhang, C.; van Dam, R.M.; Hu, F.B. Interleukin-6 genetic variability and adiposity: Associations in two prospective cohorts and systematic review in 26,944 individuals. J. Clin. Endocrinol. Metab. 2007, 92, 3618-3625.
90. Joffe, Y.T.; van der Merwe, L.; Evans, J.; Collins, M.; Lambert, E.V.; September, A.; Goedecke, J.H. Genetic polymorphisms in the Interleukin-6 gene and the risk of obesity and dyslipidaemia in black and white South African women. Genes Nutr. 2013, submitted for publication.
91. Henningsson, S.; Hakansson, A.; Westberg, L.; Baghaei, F.; Rosmond, R.; Holm, G.; Ekman, A.; Nissbrandt, H.; Eriksson, E. Interleukin-6 gene polymorphism -174G/C influences plasma lipid levels in women. Obesity 2006, 14, 1868-1873.
92. Fernandez-Real, J.M.; Broch, M.; Vendrell, J.; Richart, C.; Ricart, W. Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. J. Clin. Endocrinol. Metab. 2000, 85, 1334-1339.
93. Hulkkonen, J.; Lehtimaki, T.; Mononen, N.; Juonala, M.; Hutri-Kahonen, N.; Taittonen, L.; Marniemi, J.; Nieminen, T.; Viikari, J.; Raitakari, O. et al. Polymorphism in the IL6 promoter region is associated with the risk factors and markers of subclinical atherosclerosis in men: The Cardiovascular Risk in Young Finns Study. Atherosclerosis 2009, 203, 454-458.
94. Fontaine-Bisson, B.; Wolever, T.M.; Chiasson, J.L.; Rabasa-Lhoret, R.; Maheux, P.; Josse, R.G.; Leiter, L.A.; Rodger, N.W.; Ryan, E.A.; Connelly, P.W. et al. Genetic polymorphisms of tumor necrosis factor-α modify the association between dietary polyunsaturated fatty acids and fasting HDL-cholesterol and apo A-I concentrations. Am. J. Clin. Nutr. 2007, 86, 768-774.
95. Fontaine-Bisson, B.; El-Sohemy, A. Genetic polymorphisms of tumor necrosis factor-α modify the association between dietary polyunsaturated fatty acids and plasma high-density lipoprotein-cholesterol concentration in a population of young adults. J. Nutrigenet Nutrigenomics 2008, 1, 215-223.
96. Corpeleijn, E.; Petersen, L.; Holst, C.; Saris, W.H.; Astrup, A.; Langin, D.; MacDonald, I.; Martinez, J.A.; Oppert, J.M.; Polak, J. et al. Obesity-related polymorphisms and their associations with the ability to regulate fat oxidation in obese Europeans: The NUGENOB study. Obesity 2010, 18, 1369-1377.
97. Razquin, C.; Martinez, J.A.; Martinez-Gonzalez, M.A.; Fernandez-Crehuet, J.; Santos, J.M.; Marti, A. A Mediterranean diet rich in virgin olive oil may reverse the effects of the -174G/C IL6 gene variant on 3-year body weight change. Mol. Nutr. Food Res. 2010, 54 (Suppl. 1), 75-82.
98. Joffe, Y.T.; van der Merwe, L.; Evans, J.; Collins, M.; Lambert, E.V.; September, A.; Goedecke, J.H. UCT/MRC Research Unit for Exercise Science and Sports Medicine, University of Cape Town, Cape Town, South Africa. Unpublished work, 2013.
99. Curti, M.L.; Jacob, P.; Borges, M.C.; Rogero, M.M.; Ferreira, S.R. Studies of gene variants related to inflammation, oxidative stress, dyslipidemia, and obesity: Implications for a nutrigenetic approach. J. Obes. 2011, 2011, 497-401; doi:10.1155/2011/497401.
100. Harkins, J.M.; Moustaid-Moussa, N.; Chung, Y.J.; Penner, K.M.; Pestka, J.J.; North, C.M.; Claycombe, K.J. Expression of interleukin-6 is greater in preadipocytes than in adipocytes of 3T3-L1 cells and C57BL/6J and ob/ob mice. J. Nutr. 2004, 134, 2673-2677.
101. Eder, K.; Baffy, N.; Falus, A.; Fulop, A.K. The major inflammatory mediator interleukin-6 and obesity. Inflamm. Res. 2009, 58, 727-736.
102. Vozarova, B.; Weyer, C.; Hanson, K.; Tataranni, P.A.; Bogardus, C.; Pratley, R.E. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes. Res. 2001, 9, 414-417.
103. Shoelson, S.E.; Herrero, L.; Naaz, A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007, 132, 2169-2180.
104. Rexrode, K.M.; Pradhan, A.; Manson, J.E.; Buring, J.E.; Ridker, P.M. Relationship of total and abdominal adiposity with CRP and IL-6 in women. Ann. Epidemiol. 2003, 13, 674-682.
105. Bougoulia, M.; Triantos, A.; Koliakos, G. Plasma interleukin-6 levels, glutathione peroxidase and isoprostane in obese women before and after weight loss. Association with cardiovascular risk factors. Hormones 2006, 5, 192-199.
106. Unger, R.H. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 1995, 44, 863-870.
107. Inoguchi, T.; Li, P.; Umeda, F.; Yu, H.Y.; Kakimoto, M.; Imamura, M.; Aoki, T.; Etoh, T.; Hashimoto, T.; Naruse, M. et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-Dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 2000, 49, 1939-1945.
108. Lau, D.C.; Dhillon, B.; Yan, H.; Szmitko, P.E.; Verma, S. Adipokines: Molecular links between obesity and atheroslcerosis. Am. J. Physiol. Heart Circ. Physiol. 2005, 288, H2031-H2041.
109. Nonogaki, K.; Fuller, G.M.; Fuentes, N.L.; Moser, A.H.; Staprans, I.; Grunfeld, C.; Feingold, K.R. Interleukin-6 stimulates hepatic triglyceride secretion in rats. Endocrinology 1995, 136, 2143-2149.
110. Bastard, J.P.; Maachi, M.; Lagathu, C.; Kim, M.J.; Caron, M.; Vidal, H.; Capeau, J.; Feve, B. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur. Cytokine Netw. 2006, 17, 4-12.
111. Stouthard, J.M.; Romijn, J.A.; van der Poll, T.; Endert, E.; Klein, S.; Bakker, P.J.; Veenhof, C.H.; Sauerwein, H.P. Endocrinologic and metabolic effects of interleukin-6 in humans. Am. J. Physiol. 1995, 268, E813-E819.
112. Humphries, S.E.; Luong, L.A.; Ogg, M.S.; Hawe, E.; Miller, G.J. The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur. Heart J. 2001, 22, 2243-2252.
113. Jenny, N.S.; Tracy, R.P.; Ogg, M.S.; Luong, L.A.; Kuller, L.H.; Arnold, A.M.; Sharrett, A.R.; Humphries, S.E. In the elderly, interleukin-6 plasma levels and the -174G > C polymorphism are associated with the development of cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 2002, 22, 2066-2071.
114. Sie, M.P.; Sayed-Tabatabaei, F.A.; Oei, H.H.; Uitterlinden, A.G.; Pols, H.A.; Hofman, A.; van Duijn, C.M.; Witteman, J.C. Interleukin 6 -174 G/C promoter polymorphism and risk of coronary heart disease: Results from the rotterdam study and a meta-analysis. Arterioscler. Thromb. Vasc. Biol. 2006, 26, 212-217.
115. Walston, J.D.; Fallin, M.D.; Cushman, M.; Lange, L.; Psaty, B.; Jenny, N.; Browner, W.; Tracy, R.; Durda, P.; Reiner, A. IL-6 gene variation is associated with IL-6 and C-reactive protein levels but not cardiovascular outcomes in the Cardiovascular Health Study. Hum. Genet. 2007, 122, 485-494.
116. Joubert, J.; Norman, R.; Bradshaw, D.; Goedecke, J.H.; Steyn, N.P.; Puoane, T. Estimating the burden of disease attributable to excess body weight in South Africa in 2000. S. Afr. Med. J. 2007, 97, 683-690.
117. Lovejoy, J.C.; de la Bretonne, J.A.; Klemperer, M.; Tulley, R. Abdominal fat distribution and metabolic risk factors: Effects of race. Metab. Clin. Exp. 1996, 45, 1119-1124.
118. Goedecke, J.H.; Levitt, N.S.; Evans, J.; Ellman, N.; Hume, D.; Kotze, L.; Tootla, M.; Victor, H.; Keswell, D. The role of adipose tissue in insulin resistance in women of African Ancestry. J. Obes. 2013, 2013, 952916; doi:10.1155/2013/952916.
119. Punyadeera, C.; Crowther, N.J.; van der Merwe, M.T.; Toman, M.; Immelman, A.R.; Schlaphoff, G.P.; Gray, I.P. Metabolic response to a mixed meal in obese and lean women from two South african populations. Obes. Res. 2002, 10, 1207-1216.
120. Wells, J.C. Ethnic variability in adiposity, thrifty phenotypes and cardiometabolic risk: Addressing the full range of ethnicity, including those of mixed ethnicity. Obes. Rev. 2012, 13 (Suppl. 2), 14-29.
121. Lovejoy, J.C.; Champagne, C.M.; Smith, S.R.; de Jonge, L.; Xie, H. Ethnic differences in dietary intakes, physical activity, and energy expenditure in middle-aged, premenopausal women: The Healthy Transitions Study. Am. J. Clin. Nutr. 2001, 74, 90-95.
122. Goedecke, J.H.; Jennings, C.; Lambert, E.V. Obesity in South Africa; Medical Research Council: Cape Town, South Africa, 2006; pp. 65-79.
123. Adeboye, B.; Bermano, G.; Rolland, C. Obesity and its health impact in Africa: A systematic review. Cardiovasc. J. Afr. 2012, 23, 512-521.
124. Despres, J.P.; Couillard, C.; Gagnon, J.; Bergeron, J.; Leon, A.S.; Rao, D.C.; Skinner, J.S.; Wilmore, J.H.; Bouchard, C. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: The health, risk factors, exercise training, and genetics (HERITAGE) family study. Arterioscler. Thromb. Vasc. Biol. 2000, 20, 1932-1938.
125. Punyadeera, C.; van der Merwe, M.T.; Crowther, N.J.; Toman, M.; Schlaphoff, G.P.; Gray, I.P. Ethnic differences in lipid metabolism in two groups of obese South African women. J. Lipid Res. 2001, 42, 760-767.
126. Sumner, A.E.; Cowie, C.C. Ethnic differences in the ability of triglyceride levels to identify insulin resistance. Atherosclerosis 2008, 196, 696-703.
127. Goedecke, J.H.; Utzschneider, K.; Faulenbach, M.V.; Rizzo, M.; Berneis, K.; Spinas, G.A.; Dave, J.A.; Levitt, N.S.; Lambert, E.V.; Olsson, T. et al. Ethnic differences in serum lipoproteins and their determinants in South African women. Metabolism 2010, 59, 1341-1350.
128. Nazare, J.A.; Smith, J.D.; Borel, A.L.; Haffner, S.M.; Balkau, B.; Ross, R.; Massien, C.; Almeras, N.; Despres, J.P. Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: The international study of prediction of intra-abdominal adiposity and its relationship with cardiometabolic risk/intra-abdominal adiposity. Am. J. Clin. Nutr. 2012, 96, 714-726.
129. Corella, D.; Ordovas, J.M. Single nucleotide polymorphisms that influence lipid metabolism: Interaction with dietary factors. Annu. Rev. Nutr. 2005, 25, 341-390.
130. Ness, R.B.; Haggerty, C.L.; Harger, G.; Ferrell, R. Differential distribution of allelic variants in cytokine genes among African Americans and White Americans. Am. J. Epidemiol. 2004, 160, 1033-1038.
131. Evans, J.; Goedecke, J.H.; Soderstrom, I.; Buren, J.; Alvehus, M.; Blomquist, C.; Jonsson, F.; Hayes, P.M.; Adams, K.; Dave, J.A. et al. Depot-and ethnic-specific differences in the relationship between adipose tissue inflammation and insulin sensitivity. Clin. Endocrinol. 2011, 74, 51-59.
132. Martin, A.M.; Athanasiadis, G.; Greshock, J.D.; Fisher, J.; Lux, M.P.; Calzone, K.; Rebbeck, T.R.; Weber, B.L. Population frequencies of single nucleotide polymorphisms (SNPs) in immuno-modulatory genes. Hum. Hered. 2003, 55, 171-178.
133. Patel, J.V.; Tracey, I.; Hughes, E.A.; Lip, G.Y. Omega-3 polyunsaturated acids and cardiovascular disease: Notable ethnic differences or unfulfilled promise? J. Thromb. Haemost. 2010, 8, 2095-2104.
134. Lu, Y.; Feskens, E.J.; Dolle, M.E.; Imholz, S.; Verschuren, W.M.; Muller, M.; Boer, J.M. Dietary n-3 and n-6 polyunsaturated fatty acid intake interacts with FADS1 genetic variation to affect total and HDL-cholesterol concentrations in the Doetinchem Cohort Study. Am. J. Clin. Nutr. 2010, 92, 258-265.
135. Mathias, R.A.; Fu, W.; Akey, J.M.; Ainsworth, H.C.; Torgerson, D.G.; Ruczinski, I.; Sergeant, S.; Barnes, K.C.; Chilton, F.H. Adaptive evolution of the FADS gene cluster within Africa. PLoS One 2012, 7, e44926.
136. Sergeant, S.; Hugenschmidt, C.E.; Rudock, M.E.; Ziegler, J.T.; Ivester, P.; Ainsworth, H.C.; Vaidya, D.; Case, L.D.; Langefeld, C.D.; Freedman, B.I.; et al. Differences in arachidonic acid levels and fatty acid desaturase (FADS) gene variants in African Americans and European Americans with diabetes or the metabolic syndrome. Br. J. Nutr. 2012, 107, 547-555.
137. 1000 Genomes. Available online: http://browser.1000genomes.org (accessed on 1 February 2013).
138. Flicek, P.; Amode, M.R.; Barrell, D.; Beal, K.; Brent, S.; Carvalho-Silva, D.; Clapham, P.; Coates, G.; Fairley, S.; Fitzgerald, S. et al. Ensembl 2012. Nucl. Acids Res. 2012, 40, D84-D90.
139. Caslake, M.J.; Miles, E.A.; Kofler, B.M.; Lietz, G.; Curtis, P.; Armah, C.K.; Kimber, A.C.; Grew, J.P.; Farrell, L.; Stannard, J. et al. Effect of sex and genotype on cardiovascular biomarker response to fish oils: The FINGEN Study. Am. J. Clin. Nutr. 2008, 88, 618-629.
140. Ordovas, J.M.; Corella, D.; Cupples, L.A.; Demissie, S.; Kelleher, A.; Coltell, O.; Wilson, P.W.; Schaefer, E.J.; Tucker, K. Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: The Framingham Study. Am. J. Clin. Nutr. 2002, 75, 38-46.
141. Phillips, C.M.; Goumidi, L.; Bertrais, S.; Field, M.R.; McManus, R.; Hercberg, S.; Lairon, D.; Planells, R.; Roche, H.M. Dietary saturated fat, gender and genetic variation at the TCF7L2 locus predict the development of metabolic syndrome. J. Nutr. Biochem. 2012, 23, 239-244.
142. Phillips, C.M.; Goumidi, L.; Bertrais, S.; Field, M.R.; McManus, R.; Hercberg, S.; Lairon, D.; Planells, R.; Roche, H.M. Gene-nutrient interactions and gender may modulate the association between ApoA1 and ApoB gene polymorphisms and metabolic syndrome risk. Atherosclerosis 2011, 214, 408-414.